Introduction
A single intraperitoneal dose (75 mg/kg) of ethane-1,2-dimethanesulphonate (EDS) to male rats induces a period of sterility during Weeks 2-8 after treatment, which is associated with temporary involution of the ventral prostate and seminal vesicles. These changes have been correlated with impaired testicular androgen biosynthetic capacity (Bu'Lock & Jackson, 1975 ; Morris & McCluckie, 1979) and elevated serum LH levels (Jackson & Morris, 1977) . A 9-day course of testosterone, with the EDS given on Day 4, provided temporary protection of the spermatogenic epithelium (histologically assessed) and maintained some degree of fertility (Jackson, Jackson & Jones, 1973) ; subsequently the characteristic degenerative changes developed followed by a period of infertility. By contrast, 9 daily injections of hCG (100 i.u.) provided complete protection of the seminiferous epithelium against the EDS but infertility again developed although over a time range different from that of the testosterone experiment. These effects prompted further studies of the protective action of hCG and testosterone and a comparison with that of purified FSH and LH.
Materials and Methods
EDS. The compound is not available commercially and may be prepared as follows. To a stirred mixture of dry ethylene glycol (9-4 g) and pyridine (45 ml) cooled in an ice-salt bath, redistilled methanesulphonyl chloride (34 g) is added drop-wise from a separating funnel, the reaction temperature being maintained below 10°C. The ice bath is next removed and when the reaction mixture reaches room temperature, it is added with stirring to a prepared ice-acid mixture (a 1 litre beaker three quarters filled with crushed ice onto which concentrated sulphuric acid, 45 fig. 3 ). Similarly, although LH treatment did not fully maintain the accessory glands, their weights were substantially higher than those of rats given EDS alone or in combination with FSH. In rats treated with LH the spermatogenic epithelium appeared normal whereas in those given FSH degenerative changes were seen typical of EDS treatment alone (PI. 1, Fig. 4 ).
Mice
Infertility after EDS alone occurred in Weeks 2, 3 and 4; fertility was then restored but remained below control levels ( (Table 4) . No. of vaginal plugs 7 10 11 8 11 9 10 11 6 10 11 11 12 9 10 9 No. of litters 8 10 9 9 10 10 8 10 10 0 0 0 7 9 7 8 (Jackson et ai, 1973) .
Our earlier studies indicated that EDS essentially affects rat Leydig cells, as shown by a profound inhibition of in-vitro androgen biosynthesis by testicular tissue from rats given a single dose of the compound (Bu'lock & Jackson, 1975) . Serum androgen levels were likewise temporarily reduced over a period of 7 weeks, with maximum suppression comparable to levels in castrated animals after 24 h (Morris & McCluckie, 1979) . Histological protection of the seminiferous epithelium against the EDS action by daily treatment with testosterone propionate is a temporary phenomenon; the same dose rate will maintain spermatogenesis after hypophysectomy (Boccabella, 1963) . In spite of the normal appearance of the spermatogenic epithelium during Weeks 2-4 in rats treated with EDS + androgen for 9 days, the functional ability of spermatozoa available at this time was severely impaired (Table 1 ). This may reflect the need for direct gonado¬ trophin support during spermatid metamorphosis and sperm maturation in the epididymis, or an antifertility action of EDS on post-meiotic cells. The latter seems more likely since infertility remains when the testosterone and hCG are given for protection (Table 1) .
Leydig cell damage by EDS still occurred in testosterone-treated rats and there was no recovery even during 1 month of continued daily administration of the androgen. Evidently the latter continues to suppress the secretion of pituitary gonadotrophin necessary for the regeneration of Leydig cells. This, and the consequent lack of endogenous androgen, explains the regression of the spermatogenic epithelium, changes in organ weights (Text- fig. 1 ) and appropriately delayed onset of infertility (Table 1) (Table 2 ) and organ weights (Text- fig. 2 ), a high daily dose of hCG in conjunction with EDS had some detrimental effects on the accessory organs and functional activity of spermatozoa, although hCG alone at the same dose rate had no notable adverse effect (Table 1) . Pharmacological doses of hCG or LH can cause a rapid and profound reduction ('down regulation') in the number of binding sites for gonadotrophin on the Leydig cells of the rat. After single s.c. doses of 100-500 i.u., for example, all detectable LH/hCG receptors were reported lost and there was no testosterone secretion in response to a subsequent hCG challenge (Hsueh, Dufau & Catt, 1976 ; Hasuer & Saez, 1977 ; Sharpe, 1980) . Two consecutive doses of human LH (32 i.u., i.p) to adult rats also resulted in negligible specific binding of 125I-labelled LH in testicular homogenates by 48 h, and 10-12 days were required for restoration to normal levels (Gnanaprakasam, Chen, Sutherland & Bhalla, 1979) . On a longer time scale, daily administration of 100 i.u. hCG caused a striking decrease in receptors by 1 week but values returned to normal by 3 weeks in spite of continued treatment (Risbridger & de Kretser, 1979) . Plasma testosterone levels had risen markedly over controls by 1 week and were in the normal range by 3 weeks. The fact that 9 daily doses of hCG alone failed to influence male rat fertility (Table 2) indicates that any down-regulatory effect, with resultant reduction in testosterone production, was not detrimental to the spermatogenic process. The effects of one or two doses of gonadotrophin and rapid fall in biosynthetic capacity for testosterone production do not facilitate interpretation of the protective action of hCG against EDS Leydig cell damage. In fact, the presumed fall in testosterone production when hCG is given 3-4 days before EDS, as in the present study, might augment potential damage by the sulphonic ester. The normal testis histology in hCG-protected rats, according to current views, implies maintenance of sufficient testosterone output to the semini¬ ferous epithelium, although testicular tissue from rats treated with 100 i.u. hCG + EDS was reported to be unable to synthesize testosterone in vitro from 14C-labelled progesterone (Bu'Lock & Jackson, 1975 (Dym & Madhwa Raj, 1977 (Jackson, 1975) . The reason for the selective action of this particular compound on the Leydig cell of the rat and Japanese quail (Jones, Kominkova & Jackson, 1972) remains obscure. However, neither testosterone nor hCG were protective in the quail. In the mouse, high doses of EDS were antispermatogenic (Table 3 ) with sterility in Weeks 2-4. Testicular and epididymal weights were reduced but there was no notable effect on those of the accessory organs, whilst no histological change was seen in Leydig cells and mating was unimpaired ; an endocrine action therefore seems unlikely. This conclusion was further substantiated by the absence of a protective action with hCG or testosterone (Table 4) , favouring a direct EDS action on the spermatogenic epithelium.
The evidence presented in this paper favours direct damage to the rat Leydig cell as the specific major pharmacological action of EDS. The protective role of hCG or LH appears to be associated with Leydig cell membrane receptor occupancy preventing an interaction with EDS rather than by a cytotoxic action of the compound involving internal cellular mechanisms. The metabolic pathway of EDS is similar in rats and mice (Edwards, Jackson & Jones, 1970) 
